Hello there! Want a discount? Grab 5% OFFon your first order!
originalresearchpapers.com logo
Hello there! Want a discount? Grab 5% OFF on your first order!
originalresearchpapers.com logo

UC Berkeley Chimeric Antigen Receptor T Cell Hematology Discussion Nursing Assignment Help

I need help with a Health & Medical question. All explanations and answers will be used to help me learn.

There has been a recent surge of excitement regarding advances in the development of so called Chimeric Antigen Receptor T cell  (CAR-T) technology for the treatment of hematological malignancy, particularly ALL.  

For this discussion you will consider the strategies, successes, and risks associated with this new therapeutic approach. Begin by reading this article: Vicki Brower, “The CAR T-cell race (Links to an external site.),” The Scientist, (April 1, 2015). Next, focus on one biotech company or one university research group that has been at the forefront of CAR-T cell research. You can choose one of the groups listed in the above article, or you can identify another group through your own online research.

Compose a brief, ~ 300-500 word report that explains the specific CAR-T cell approach being implemented and the most up-to-date clinical data you can find regarding the status of the therapy they have developed. In your report you should also consider some of the various risks that may be associated with this therapy and any strategies the researchers are invoking to alleviate these risks.

Expert Solution Preview

Introduction:
The recent advancements in Chimeric Antigen Receptor T cell (CAR-T) technology have generated considerable excitement in the medical field, particularly in the treatment of hematological malignancies such as Acute Lymphoblastic Leukemia (ALL). This discussion aims to explore the strategies, successes, and risks associated with CAR-T cell therapy. Specifically, we will focus on one biotech company or university research group that has been at the forefront of CAR-T cell research.

Answer:

One of the leading groups in CAR-T cell research is the University of Pennsylvania (UPenn) Perelman School of Medicine. They have made significant strides in developing and implementing CAR-T cell therapy for the treatment of hematological malignancies. The therapy they have developed primarily involves the modification of a patient’s own T cells to express chimeric antigen receptors, allowing them to recognize and attack cancer cells.

The most up-to-date clinical data regarding UPenn’s CAR-T cell therapy, known as CTL019, is highly encouraging. A clinical trial conducted by UPenn researchers showed remarkable response rates in pediatric and adult patients with relapsed/refractory ALL. The trial reported a complete remission rate of approximately 90% in pediatric patients and 57% in adult patients. Moreover, the therapy demonstrated durable responses, with a median event-free survival of 6.1 months and a median overall survival of 12.9 months in pediatric patients.

Despite the promising results, there are potential risks associated with CAR-T cell therapy. The infusion of modified T cells can lead to severe cytokine release syndrome (CRS). CRS is a systemic inflammatory response caused by the activation and proliferation of T cells, resulting in fever, hypotension, capillary leak, and organ dysfunction. In some cases, CRS can be life-threatening. Additionally, neurologic toxicities, such as encephalopathy and seizures, have been reported in patients receiving CAR-T cell therapy. These toxicities are believed to be associated with increased activation and migration of T cells into the central nervous system.

To mitigate these risks, researchers at UPenn have implemented several strategies. Firstly, they have developed clinical protocols to closely monitor and manage CRS and neurologic toxicities. This includes administering tocilizumab, an interleukin-6 receptor antagonist, to control severe CRS, and providing supportive care to manage neurologic toxicities. Secondly, ongoing research is focused on optimizing the design and engineering of CAR-T cells to enhance their anti-cancer efficacy while minimizing adverse effects. This includes exploring the use of inducible CAR-T cells and dual-targeted CAR-T cells to enhance specificity and reduce off-tumor effects.

In conclusion, the University of Pennsylvania’s CAR-T cell therapy, CTL019, has shown promising results in the treatment of relapsed/refractory ALL. While there are risks associated with CAR-T cell therapy, particularly severe cytokine release syndrome and neurologic toxicities, researchers at UPenn are actively working on strategies to minimize these risks. Through the continuous refinement of protocols and the exploration of advanced engineering techniques, CAR-T cell therapy holds great potential in revolutionizing the treatment of hematological malignancies.

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

The assignment will be used to develop a written Nursing Assignment Help

The assignment will be used to develop a written implementation plan. Step 1) Review your strategic plan to implement the change proposal, the objectives, the outcomes, and listed resources. Step 2) Develop a process to evaluate the intervention if it were implemented. Step 3) Write a 150-250 word summary of the evaluation plan

Assessment Description Throughout the RN-to-BSN program, Nursing Assignment Help

Assessment Description Throughout the RN-to-BSN program, students are required to participate in scholarly activities outside of clinical practice or professional practice. Examples of scholarly activities include attending conferences, seminars, journal club, grand rounds, morbidity and mortality meetings, interdisciplinary committees, quality improvement committees, and any other opportunities available at your site,

1)Based on how you will evaluate your EBP project, which Nursing Assignment Help

1)Based on how you will evaluate your EBP project, which independent and dependent variables do you need to collect? Why?  2)Not all EBP projects result in statistically significant results. Define clinical significance and explain the difference between clinical and statistical significance. How can you use clinical significance to support positive

Bad Sugar” which explores the causes and effects of diabetes

Bad Sugar” which explores the causes and effects of diabetes within two Native American communities. •  “Place Matters” which connects the dots between health, wealth, and zip codes. •  After reviewing both video transcripts, discuss how the factors listed below can influence health behaviors and health status. Support your discourse

Select two underdeveloped countries and examine the key Nursing Assignment Help

Select two underdeveloped countries and examine the key determinants of health. Compare and contrast the healthcare systems, economy, and healthcare system challenges, such as access to care and health disparities. Use the Eight Factor Model to assess the strengths and weaknesses of the healthcare systems and determine the extent to

Two groups of symptoms found with schizophrenia spectrum and Nursing Assignment Help

Two groups of symptoms found with schizophrenia spectrum and related psychotic disorders are “positive” and “negative” symptoms. Positive symptoms generally “add” and include things such as delusions, hallucinations, and repetitive movements. Negative symptoms generally “detract” and may include difficulty showing emotions, withdraw from social relationships, or apathy. While many disorders

Value-based care is a healthcare delivery model in which Nursing Assignment Help

Value-based care is a healthcare delivery model in which providers, including hospitals and physicians, are paid on the basis of patient health outcomes. Value-based care includes three key goals: improved population health, increased patient satisfaction, and reduced cost. Each of these goals affects the stakeholders differently. For example, value-based care

Scenario Upper management has been watching and is impressed Nursing Assignment Help

Scenario Upper management has been watching and is impressed by the work you have done as project lead to gather information for this departmental expansion project. Your administrator passes along their request that you use your skills in project management to explain health care facility design project management by creating a proposal of what this project

IHP 630 Module Four Project Preparation Guidelines and Nursing Assignment Help

IHP 630 Module Four Project Preparation Guidelines and RubricOverview In this module, you learned about how governmental and nongovernmental health insurance models impact financial management and strategic planning in a healthcare organization. You also explored the reporting requirements for payers. In this activity, you will create a report that compares

You deserve a bonus!

Subscribe and get regular bonuses and discounts.